Publications by authors named "D Ertoy Baydar"
Article Synopsis
- Localized cystic disease of the kidney (LCDK) is a rare, non-progressive condition that can be mistaken for cancer, potentially leading to unnecessary surgeries.
- In a study of 14 patients (ages 3-79, mostly middle-aged), most cases presented as unilateral and many patients experienced flank pain or had incidental findings.
- The lesions were multilocular and benign, lacking malignant features, and a review of 75 other cases supports the idea that LCDK should be included in the differential diagnosis for cystic kidney lesions.
Objectives: We aimed to modify the Briganti 2019 nomogram and to test whether it is valid for patients who were diagnosed with prostate cancer through in-bore prostate biopsies.
Methods: Data for 204 patients with positive multiparametric prostate MRI and prostate cancer identified either by mpMRI-cognitive/software fusion or in-bore biopsy and who underwent robot-assisted radical prostatectomy and extended pelvic lymph node dissection between 2012 and 2023 were retrospectively analyzed. The Briganti 2019 nomogram was applied to the mpMRI-cognitive/software fusion biopsy group (142 patients) in the original form, and then, two modifications were tested for the targeted component.
Introduction: The follow-up findings of patients who underwent prostate biopsy for prostate image reporting and data system (PIRADS) 4 or 5 multiparametric magnetic resonance imaging (mpMRI) findings and had benign histology were retrospectively reviewed.
Methods: There were 190 biopsy-naive patients. Patients with at least 12 months of follow-up between 2012 and 2023 were evaluated.
Background: To investigate the predictable parameters associated with downgrading in patients with a Gleason score (GS) 8 (4+4) in prostate biopsy after radical prostatectomy.
Methods: We retrospectively analyzed 62 patients with a GS of 4+4 on prostate biopsy who underwent robotic radical prostatectomy between 2017 and 2022.
Results: 38 of 62 (61.